Vimian Group AB

VIMIAN

SE0015961982

Pharmaceuticals

Market Closed - Nasdaq Stockholm Other stock markets 11:29:54 2024-04-29 am EDT			5-day change	1st Jan Change
30.05 ^SEK	+2.21%		-3.69%	+1.52%

Mar. 28	Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss	DJ
Mar. 19	Nordic Stocks Decreased Tuesday; Autostore Holdings Posted Biggest Loss	DJ

Vimian Group AB Announces Fredrik Ullman Step Down as CEO

June 29, 2023 at 08:15 am EDT

Vimian Group AB (publ) announced that CEO Fredrik Ullman, following consultation with the Board, steps down as CEO. Fredrik Ullman has been the CEO of Vimian since its inception in 2020 and the CEO of its subsidiary Indical Bioscience since 2018. The recruitment process for a new CEO will be initiated immediately with Fredrik Ullman remaining as CEO in the interim and at the latest until year-end.

The recruitment process for a new CEO will be initiated immediately and Fredrik Ullman will remain as CEO in the interim.

Latest news about Vimian Group AB

Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss	Mar. 28	DJ
Nordic Stocks Decreased Tuesday; Autostore Holdings Posted Biggest Loss	Mar. 19	DJ
Nordic Stocks Dropped Monday; Zealand Pharma Took Biggest Hit	Mar. 11	DJ
Vimian Group to Launch SEK1.63 Billion Rights Issue for Acquisition Ventures	Mar. 08	MT
Transcript : Vimian Group AB - Shareholder/Analyst Call	Mar. 08
Vimian Group Nominates New Chairman	Feb. 28	MT
Vimian Group AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 15	CI
Transcript : Vimian Group AB, 2023 Earnings Call, Feb 15, 2024	Feb. 15
Vimian Group AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 15	CI
Sweden's Vimian Names Successor to Outgoing CEO	Dec. 21	MT
Vimian Group AB Announces CEO Changes	Dec. 21	CI
Nordic Shares Moved Upward Tuesday; Vimian Group Led Increases	Dec. 19	DJ
Nordic Stocks Declined Tuesday; Vitrolife Took Biggest Hit	Dec. 12	DJ
Nordic Shares Closed Up Friday; engcon Cl B Climbed Highest	Dec. 08	DJ
Nordic Stocks Moved Upward Wednesday; Vimian Group Led Increases	Nov. 29	DJ
Vimian Group AB Announces Management Changes	Nov. 15	CI
Transcript : Vimian Group AB, Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Vimian Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Nordic Shares Closed Up Wednesday; ALK-Abello Series B Led Increases	23-10-04	DJ
Nordic Shares Dropped Monday; Sampo Series A Fell Furthest Nordic Stocks	23-10-02	DJ
Fidelio Capital acquired a 12% stake in Vimian Group AB for approximately SEK 240 million.	23-09-24	CI
Nordic Stocks Rose Wednesday; Volvo Car Series B Led Increases	23-09-20	DJ
Nordic Shares Decreased Tuesday; Beijer Ref Series B Posted Biggest Loss	23-09-19	DJ
Nordic Stocks Dropped Monday; Nordic Semiconductor Fell Furthest	23-09-18	DJ
Nordic Stocks Declined Friday; H&M Hennes & Mauritz B Took Biggest Hit	23-09-15	DJ

Chart Vimian Group AB

Duration

Period

More charts

Company Profile

Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.

Sector

Pharmaceuticals

Calendar

2024-05-02 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Vimian Group AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.566 EUR

Average target price

3.355 EUR

Spread / Average Target

+30.72%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
VIMIAN GROUP AB	+1.52%	1.44B
ZOETIS INC.	-19.09%	72.97B
ELANCO ANIMAL HEALTH INCORPORATED	-8.93%	6.69B
BLUESTAR ADISSEO COMPANY	+21.38%	3.6B
JINYU BIO-TECHNOLOGY CO., LTD.	-16.99%	1.34B
VETOQUINOL SA	-3.81%	1.25B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-26.05%	1.24B
WUHAN KEQIAN BIOLOGY CO.,LTD	-12.71%	1.15B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-4.03%	1.01B
PULIKE BIOLOGICAL ENGINEERING, INC.	-23.05%	817M

Veterinary Drugs

Vimian Group AB

Equities

VIMIAN

SE0015961982

Pharmaceuticals

Vimian Group AB Announces Fredrik Ullman Step Down as CEO

EPS Revisions